Ami Shah, MD, MHSDirector, Division of Rheumatology
- Clinical Investigation Training (M.H.S.): Johns Hopkins Bloomberg School of Public Health
- Residency in Internal Medicine: Stanford University Hospital and Clinics
- Rheumatology Fellowship: Johns Hopkins University School of Medicine
Dr. Ami Shah is an Associate Professor of Medicine, Director of the Division of Rheumatology, and Co-Director of the Johns Hopkins Scleroderma Center. Dr. Shah is a graduate of the Massachusetts Institute of Technology and the Johns Hopkins University School of Medicine. She completed her internal medicine residency training at Stanford University Hospital & Clinics. She returned to Johns Hopkins for her rheumatology post-doctoral fellowship. During her fellowship training, she also earned her Master in Health Sciences degree in Clinical Investigation at the Johns Hopkins Bloomberg School of Public Health.
Dr. Shah’s clinical practice is focused on the broad spectrum of patients with scleroderma and related disorders, and her expertise includes management of complications such as Raynaud’s phenomenon, digital ischemia, pulmonary hypertension, cardiac dysfunction, myopathy, aggressive skin disease, and concomitant cancer. Dr. Shah teaches post-doctoral fellows in her clinic about the evaluation and management of scleroderma.
Dr. Shah has an active research program studying various aspects of scleroderma and Raynaud’s phenomenon. She is investigating the connection between cancer and scleroderma, as her early data suggest cancer may drive the development of scleroderma in some patients. She also conducts epidemiological studies and participates in clinical trials to examine 1) methods to detect cardiopulmonary complications in scleroderma, 2) biological and imaging markers of Raynaud’s severity, and 3) drugs that may improve various aspects of the disease (such as skin, lung or vascular complications).